186 related articles for article (PubMed ID: 35013116)
1. RNA-binding protein p54
Shen M; Zhang R; Jia W; Zhu Z; Zhao L; Huang G; Liu J
Cell Death Dis; 2022 Jan; 13(1):42. PubMed ID: 35013116
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
Kim SJ; Ju JS; Kang MH; Eun JW; Kim YH; Raninga PV; Khanna KK; Győrffy B; Pack CG; Han HD; Lee HJ; Gong G; Shin Y; Mills GB; Eyun SI; Park YY
Theranostics; 2020; 10(18):7974-7992. PubMed ID: 32724453
[TBL] [Abstract][Full Text] [Related]
3. Nuclear scaffold protein p54
Shen M; Zhang R; Jia W; Zhu Z; Zhao X; Zhao L; Huang G; Liu J
Oncogene; 2021 Jun; 40(24):4167-4183. PubMed ID: 34079086
[TBL] [Abstract][Full Text] [Related]
4. p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A.
Zhu Z; Zhao X; Zhao L; Yang H; Liu L; Li J; Wu J; Yang F; Huang G; Liu J
Oncogene; 2016 Mar; 35(11):1399-410. PubMed ID: 26148231
[TBL] [Abstract][Full Text] [Related]
5. Interfering MSN-NONO complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer.
Qin Y; Chen W; Jiang G; Zhou L; Yang X; Li H; He X; Wang HL; Zhou YB; Huang S; Liu S
Sci Adv; 2020 Feb; 6(8):eaaw9960. PubMed ID: 32128390
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO.
Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453
[TBL] [Abstract][Full Text] [Related]
7. IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer.
de Silva HC; Lin MZ; Phillips L; Martin JL; Baxter RC
Cell Mol Life Sci; 2019 May; 76(10):2015-2030. PubMed ID: 30725116
[TBL] [Abstract][Full Text] [Related]
8. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
9. Structure, Dynamics, and Interaction of p54(nrb)/NonO RRM1 with 5' Splice Site RNA Sequence.
Duvignaud JB; Bédard M; Nagata T; Muto Y; Yokoyama S; Gagné SM; Vincent M
Biochemistry; 2016 May; 55(18):2553-66. PubMed ID: 27064654
[TBL] [Abstract][Full Text] [Related]
10. Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer.
Brand TM; Iida M; Dunn EF; Luthar N; Kostopoulos KT; Corrigan KL; Wleklinski MJ; Yang D; Wisinski KB; Salgia R; Wheeler DL
Mol Cancer Ther; 2014 May; 13(5):1356-68. PubMed ID: 24634415
[TBL] [Abstract][Full Text] [Related]
11. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
Lu JY; Sewer MB
Mol Cell Biol; 2015 Apr; 35(7):1223-37. PubMed ID: 25605330
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of P54(nrb) /NonO correlates with collagen deposition and fibrosis in human aortic dissection.
Ren Z; Wang Z; Hu Z; Hu X; Zhang H; Wu H; Hu R; Liu H
Histopathology; 2014 Oct; 65(4):570-80. PubMed ID: 24720418
[TBL] [Abstract][Full Text] [Related]
13. NONO and tumorigenesis: More than splicing.
Feng P; Li L; Deng T; Liu Y; Ling N; Qiu S; Zhang L; Peng B; Xiong W; Cao L; Zhang L; Ye M
J Cell Mol Med; 2020 Apr; 24(8):4368-4376. PubMed ID: 32168434
[TBL] [Abstract][Full Text] [Related]
14. The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing NONO.
Shi X; Huang X; Chen R; Li Y; Xu Y; Zhang W; Zhu Q; Zha X; Wang J
Clin Exp Metastasis; 2021 Dec; 38(6):551-571. PubMed ID: 34714466
[TBL] [Abstract][Full Text] [Related]
15. Splicing Regulator p54
Hu Z; Dong L; Li S; Li Z; Qiao Y; Li Y; Ding J; Chen Z; Wu Y; Wang Z; Huang S; Gao Q; Zhao Y; He X
Hepatology; 2020 Aug; 72(2):548-568. PubMed ID: 31815296
[TBL] [Abstract][Full Text] [Related]
16. The transcription-splicing protein NonO/p54nrb and three NonO-interacting proteins bind to distal enhancer region and augment rhodopsin expression.
Yadav SP; Hao H; Yang HJ; Kautzmann MA; Brooks M; Nellissery J; Klocke B; Seifert M; Swaroop A
Hum Mol Genet; 2014 Apr; 23(8):2132-44. PubMed ID: 24301678
[TBL] [Abstract][Full Text] [Related]
17. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.
Powell CA; Nasser MW; Zhao H; Wochna JC; Zhang X; Shapiro C; Shilo K; Ganju RK
Oncotarget; 2015 Mar; 6(8):6373-85. PubMed ID: 25779666
[TBL] [Abstract][Full Text] [Related]
19. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription.
Sewer MB; Nguyen VQ; Huang CJ; Tucker PW; Kagawa N; Waterman MR
Endocrinology; 2002 Apr; 143(4):1280-90. PubMed ID: 11897684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]